Towards a Mexican normative standard for measurement of the short format 36 health-related quality of life instrument;Hacia una base normativa Mexicana en la medición de calidad de vida relacionada con la salud, mediante el formato corto 36

Salud Publica de Mexico

Volumn 46, Issue 4, 2004, Pages 306-315

  Durán Arenas, Luis ^a,b   Gallegos Carrillo, Katia ^a   Salinas Escudero, Guillermo ^a   Martínez Salgado, Homero ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Reforma 476 ^*  (Mexico)

Author keywords

Mexico; Normative values; Qua lity of life related to health; Regional variations

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALCULATION; CANADA; DATA ANALYSIS; FEMALE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; MALE; MEASUREMENT; MENTAL HEALTH; MEXICO; NORMAL HUMAN; POPULATION RESEARCH; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEX DIFFERENCE; SHORT FORMAT 36; SOCIAL STATUS; STANDARD; UNITED STATES;

EID: 4544327981     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0036-36342004000400005     Document Type: Article

References (29)

1. Zúñiga AM, Carrillo JGT, Fos PJ, Gandek B, Medina MRM. Evaluación del estado de salud con la encuesta SF-36. Resultados preliminares en México. Salud Publica Mex 1999;41:110-118.
2. Velarde E, Avila C. Evaluación de la calidad de vida. Salud Publica Mex; 44(4):349-361.
3. Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C et al. Canadian normative data for the Sf-36: The need for regional norms. J Public Health Med 1995;17:46-50.
4. Hopman WM, Berger C, Joseph L, Towheed T, Anastassiades T, Tenenhouse A et al. Is there regional variation in the SF-36 scores of Canadian adults? Can J Public Health. 2002 May-Jun;93(3):233-237.
5. Wood-Dauphinne SW. The Canadian SF-36 health survey. Normative data add to its value. CMAJ 2000;163:284-284.
6. Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and measures: Summary of results from the Medical Outcomes Study. Med Care 1995;33 (4 suppl):AS264-AS279.
7. Ware JE Jr, Sherbourne CD. The MOS 36-item short form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-483.
8. Ware JE. SF-36 health survey manual and interpretation guide. Boston (MA): The Health Institute, New England Medical Centre; 1993.
9. Ware JE.The SF-36 health survey. En: Spilker B, ed. Quality of life and pharmaco-economics in clinical trials. Second Edition. Philadelphia (PA): Lippincott-Raven Publisher; 1996:337-345.
10. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scale: A User's manual. Boston (MA): The Health Institute, New England Medical Centre; 1994.
11. Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health 1999;53:46-50.
12. Jenkinson C, Coulter C, Wright L. Short form 36 (SF-36) health survey questionnaire: Normative data for adults of working age. BMJ 1993;306:1437-1440.
13. Beaton DE, Hogg-Johnson S, Bombardier C. Evaluating changes in health status: Reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol 1997;50:79-93.
14. Berzon RA, Understanding and using health-related quality of life instruments within clinical research studies. En: Staquet MJ, Hays RD, Fayers FM, ed. Quality of life assessments in clinical trials: Methods and practice. Oxford: Oxford University Press; 1998:3-15.
15. Essink-Bot ML, Krabbe PFM, Bonsel GJ, Aaroson NK. An empirical comparison of four generic health status measures. Med Care 1997;35:522-537.
16. Hemingway H, Stafford M, Stanfield S, Shipley M, Marmot M. Is the SF-36 a valid measure of change in population health? Result from the Whitehall II study. BMJ 1997;315:1273-1279.
17. Kreiger N, Tenenhouse A, Joseoh L, Mackenzie T, Poliquin S, Brown JP et al. The Canadian Multicentre Osteoporosis Study (Camos): Background, rationale, methods. Can J Aging 1999;18:376-387.
18. Lyons RA, Fielder H, Littlepage NC. Measuring health status with the SF-36: The need for regional norms. J Public Health Med 1995;17:46-50.
19. McHorney CA, Ware JE Jr, Raczek AE. Them MOS 36-item short form health survey (SF-36): II. Psychometric and clinical test of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
20. McHorney CA, Ware JE Jr, Lu JFR, Sherbourne CD. The MOS 36-item short form health survey: III. Test of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
21. Melzoff J. Critical thinking about research: Psychology and related fields. Washington, DC: American Psychological Associations; 1998.
22. Mishra G, Schofield MJ. Norms for the physical and mental health component summary scores of the SF-36 for young, middle-aged and older Australian women. Qual Life Res 1998;7:215-220.
23. Raftery A, Lewis S. How many iterations in the Gibbs sampler? En: Bernardo JM, Berger JO, Dawid JO, Smith AFM, ed. Bayesian statistics 4. Oxford: Oxford University Press, 1992;763-773.
24. Rubin D. Multiple imputation for non-respondents in surveys. New York (NY): John Wiley & Sons; 1987.
25. Spiegelhter DJ, Thomas A, Best NG, Gilks WR. BUGS: Bayesian inference using Gibbs sampling, Version 0.5, (version ii). Cambridge, UK: MRC Biostatistics Unit; 1996.
26. Statistics Canada provincial census data, 1991. Age, sex and marital status. The Nation Ottawa: Statistics Canada; 1993. (Cat. No. 93-310).
27. Statistics Canada Provincial Census Data, 1991. Profile of census metropolitan areas and census agglomeration, part A. Ottawa: Statistics Canada; 1993. (Cat. No. 93-337).
28. Watson EK, Firman DW, Baade PD, Ring I. Telephone administration of the SF-36 health survey: Validation studies and population norms for adults in Queensland, Aust. N Z J Public Health 1996;20:359-363.
29. Wood-Dauphinee SW, Gauthier L, Gandek B, Magnan L, Pierre U. Readying a US measure of health status, for use in Canada. Clin Invest Med 1997;20:224-238.